General information

Announcements(1)

Program

Sessions

Search presentations

Timetable

Tue. Mar 10, 2026

Wed. Mar 11, 2026

Thu. Mar 12, 2026

web_header_en.png

web_icon_ja.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

企画

Profile management

Announcements

Bookmark

Download PDF for print

Utilization of Digital Biomarkers in Drug Development

Recently, wearable devices such as smartwatches have allowed us to monitor and record a variety of activities and signals in humans over time. By analyzing such quantitative and objective measurements called "digital biomarkers," there is a growing trend to not only visualize health conditions in daily life and the effects of various interventions on disease treatment, but also to realize early diagnosis and prediction of diseases. In this background, different industries including pharmaceutical companies intend to utilize digital biomarkers in order to advance medical care and healthcare. Nevertheless, relevance of these parameters to physiological and pathological significance have not yet been fully understood; this standpoint requires physiologists to play essential roles. The symposium invites leading experts from industry, government, and academia who are actively working on digital biomarkers to share the current status of their utilization and discuss the prospects.

【J】Utilization and application of "digital biomarker": status quo and prospects

The 103rd Annual Meeting of The Physiological Society of Japan

Presentation Information

[1S01m-04]Utilization of Digital Biomarkers in Drug Development

Keywords:

Password required to view

Comment